Method for preparing prostate acid phosphatase antigen for pulsing dendritic cells for prostate cancer immunotheraphy
KR20080109705A
Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression
KR20090005472A
Autologous dendritic cell mediated by photodynamic therapy having the ability to suppress the growth of tumor
KR20080101988A
Animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above
KR20080095343A
Pharmaceutical compositions for treating rheumatoid arthritis comprising semi-mature dendritic cell
KR20080078204A
Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression
KR100647844B1
Animal Models Carrying Tumors Expressing Human Prostate Cancer-Specific Antigen and Method for Analyzing Prevention Efficacy of Dendritic Cells-Derived Immunotherapeutics Using the Above
KR20070109122A
Novel use of mln51 gene and protein
KR20060122623A
Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals
KR100647847B1
- Animal Models Carrying Tumors Expressing Human Prostate Cancer-Specific Antigen and Method for Analyzing Prevention and Treatment Efficacy of Dendritic Cells-Derived Immunotherapeutics Using the Above
US2006045889A1
Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)
US7101844B2
Cytoplasmic transduction peptides and uses thereof
KR20040050346A
Novel Recombinant Sabin Type 1 Poliovirus Vector and Vaccine Against Poliovirus
KR20030078429A
Novel Dendritic Cell-Specific Polynucleotides and Microarray Comprising the Same
KR20030078430A
Novel Recombinant Poliovirus Vectors and Vaccine Compositions Capable of Inducing Cytotoxic T Lymphocytes
KR20030070454A
Method of Preparing Mature Dendritic Cell-Vaccine for Immunotherapy
KR20030056371A
Vector for expression of mouse granulocyte-macrophage colony stimulating factor and a transformant transformed with the vector
KR20030012197A
The preparation method of recombinant human Interleukin-4
KR20020083634A
Pharmaceutical Compositions Comprising Dendritic Cells for Immunotherapy of Autoimmune Disease and Treatment Method Using the Same
KR20020066048A
Method for Improving a Genetic Stability for the Insert in Single-Stranded RNA Virus Recombinant Vectors
